SIRINTORN MANN: Open Payments
NPI 1982608576 · DANVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$981 in 33 payments from 12 companies in 2025. Trend: 2023 $316 · 2024 $202 · 2025 $981
Food & beverage: $938Education: $43
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $231 |
| Novo Nordisk Inc | 8 | $188 |
| Abbott Laboratories | 4 | $86 |
| Ascendis Pharma Endocrinology Inc | 3 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $79 |
| Mannkind Corporation | 2 | $65 |
| Amgen Inc. | 2 | $58 |
| Radius Health, Inc. | 2 | $56 |
| Medtronic, Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $46 |
Products named: DEXCOM G7 GSS (161), Ozempic, FREESTYLE LIBRE 3, Yorvipath, JARDIANCE, Dexcom G6 Transmitter, AFREZZA, TEPEZZA.
Industry payments across CA — which companies pay providers there.
